en

PRODUCT DETAIL

Enbrel 25 mg prášok a rozpúšťadlo na injekčný roztok

Code 03260
MA number EU/1/99/126/003
Product Form: plv iol 4x25 mg + 4x1 ml solv. (liek.inj.skl.+striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Pfizer Europe MA EEIG, Belgium
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB01 Etanercept
Shelf life: 48
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application
MA issued: 03.02.2000
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.10.2021
eu-flag.png sk-flag.png